Progressive muscular weakness and loss of function can severely impact independence and quality of life in certain conditions. Like Duchenne Muscular Dystrophy (DMD) and other inflammatory neuromuscular disorders. Dyscort–30 helps delay disability, preserve muscle function, and improve long-term outcomes in neurological care. With proven tolerability and reduced metabolic side effects compared to traditional corticosteroids, it offers safer and sustained functional support.

• Delays loss of ambulation and preserves muscle strength
• Improves pulmonary and cardiac function
• Offers better tolerability than Prednisolone
• Reduces the need for scoliosis surgery
• Minimizes weight gain and metabolic complications
• Maintains a safer bone profile